We are live on ! Find out more
AKYA icon

Akoya BioSciences

Delisted

AKYA was delisted on the 7th of July, 2025.

0 hedge funds and large institutions have $0 invested in Akoya BioSciences in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

25.1% less ownership

Funds ownership: 25.1% → 0% (-25%)

100% less funds holding

Funds holding: 58 → 0 (-58)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $16.3M

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 58

Holders
–
Holders Change
-58
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
58
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AKYA Hedge Fund Activity: Q3 2025 in Review

0 of the 7,665 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q3 2025, worth a combined $0 — down 100% from $16.3M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of AKYA and 0 opened new positions — a net loss of 58 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Blue Water Life Science Advisors, exiting entirely with an estimated $6.11M sold.

  • 0 institutional investors held Akoya BioSciences (AKYA) as of Q3 2025, down from 58 in Q2 2025.
  • Funds reported $0 of Akoya BioSciences stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Akoya BioSciences positions in Q3 2025 and 58 closed out, a net change of -58 holders.
  • The largest Akoya BioSciences seller in Q3 2025 was Blue Water Life Science Advisors, an estimated $6.11M sold.

Based on aggregated 13F filings for Q3 2025.